The global longevity and anti-senescence therapies market should grow from $329.8 million in 2018 to $644.4 million by 2023 with a compound annual growth rate (CAGR) of 14.3% during 2018-2023.

Report Scope:

The scope of this report is broad and covers various therapies currently under trials in the global longevity and anti-senescence therapy market. The market estimation has been performed with consideration for revenue generation in the forecast years 2018-2023 after the expected availability of products in the market by 2023. The global longevity and anti-senescence therapy market has been segmented by the following therapies: Senolytic drug therapy, Gene therapy, Immunotherapy and Other therapies which includes stem cell-based therapies, etc.

Request for Report Sample:https://www.trendsmarketresearch.com/report/sample/11698

Revenue forecasts from 2028 to 2023 are given for each therapy and application, with estimated values derived from the expected revenue generation in the first year of launch.

The report also includes a discussion of the major players performing research or the potential players across each regional longevity and anti-senescence therapy market. Further, it explains the major drivers and regional dynamics of the global longevity and anti-senescence therapy market and current trends within the industry.

The report concludes with a special focus on the vendor landscape and includes detailed profiles of the major vendors and potential entrants in the global longevity and anti-senescence therapy market.

Report Includes:

71 data tables and 40 additional tables An overview of the global longevity and anti-senescence therapy market Analyses of global market trends, with data from 2017 and 2018, and projections of compound annual growth rates (CAGRs) through 2023 Country specific data and analysis for the United States, Canada, Japan, China, India, U.K., France, Germany, Spain, Australia, Middle East and Africa Detailed description of various anti-senescence therapies, such as senolytic drug therapy, gene therapy, immunotherapy and other stem cell therapies, and their influence in slowing down aging or reverse aging process Coverage of various therapeutic drugs, devices and technologies and information on compounds used for the development of anti-ageing therapeutics A look at the clinical trials and expected launch of anti-senescence products Detailed profiles of the market leading companies and potential entrants in the global longevity and anti-senescence therapy market, including AgeX Therapeutics, CohBar Inc., PowerVision Inc., T.A. Sciences and Unity Biotechnology

Summary

Global longevity and anti-senescence therapy market deals in the adoption of different therapies and treatment options used to extend human longevity and lifespan. Human longevity is typically used to describe the length of an individuals lifetime and is sometimes used as a synonym for life expectancy in the demography. Anti-senescence is the process by which cells stop dividing irreversibly and enter a stage of permanent growth arrest, eliminating cell death. Anti-senescence therapy is used in the treatment of senescence induced through unrepaired DNA damage or other cellular stresses.

Global longevity and anti-senescence market will witness rapid growth over the forecast period (2018-2023) owing to an increasing emphasis on Stem Cell Research and an increasing demand for cell-based assays in research and development.

An increasing geriatric population across the globe and a rising awareness of antiaging products among generation Y and later generations are the major factors expected to promote the growth of global longevity and anti-senescence market. Factors such as a surging level of disposable income and increasing advancements in anti-senescence technologies are also providing traction to the global longevity and anti-senescence market growth over the forecast period (2018-2023).

According to the National Institutes of Health (NIH), the total geriatric population across the globe in 2016 was over REDACTED. By 2022, the global geriatric population (65 years and above) is anticipated to reach over REDACTED. An increasing geriatric population across the globe will generate huge growth prospectus to the market.

Senolytics, placenta stem cells and blood transfusions are some of the hot technologies picking up pace in the longevity and anti-anti-senescence market. Companies and start-ups across the globe such as Unity Biotechnology, Human Longevity Inc., Calico Life Sciences, Acorda Therapeutics, etc. are working extensively in this field for the extension of human longevity by focusing on study of genomics, microbiome, bioinformatics and stem cell therapies, etc. These factors are poised to drive market growth over the forecast period.

Global longevity and anti-senescence market is projected to rise at a CAGR of REDACTED during the forecast period of 2018 through 2023. In 2023, total revenues are expected to reach REDACTED, registering REDACTED in growth from REDACTED in 2018.

The report provides analysis based on each market segment including therapies and application. The therapies segment is further sub-segmented into Senolytic drug therapy, Gene therapy, Immunotherapy and Others. Senolytic drug therapy held the largest market revenue share of REDACTED in 2017. By 2023, total revenue from senolytic drug therapy is expected to reach REDACTED. Gene therapy segment is estimated to rise at the highest CAGR of REDACTED till 2023. The fastest growth of the gene therapy segment is due to the Large investments in genomics. For Instance; The National Human Genome Research Institute (U.S.) had a budget grant of REDACTED for REDACTED research projects in 2015, thus increasing funding to REDACTED for approximately REDACTED projects in 2016.

More Info of Impact Covid19@https://www.trendsmarketresearch.com/report/covid-19-analysis/11698

Continued here:
Longevity And Anti-Senescence Therapy Market Value Chain and Forecast COVID-19 2023 - Kentucky Journal 24

Amid speculations over Covid-19 vaccines, a top official from the Indian Medical Association (IMA) has reportedly claimed that a vaccine would reach usable stage only after 2020.

A usable vaccine to cure COVID-19 and bringing the same to good use would go beyond 2020, a news agency quoted an Dr V K Monga, IMA Board of Hospitals Chairman as saying.

He said that developing a vaccine for viral infections is a longer process as firstly, these infections have shorter immunity and secondly, viruses mutate faster, so this makes developers clueless as to which mutation is there in which part of the country.

Dr Monga further said for developing a vaccine there are multiple stages and steps.

Developing a vaccine is not a political decision, it involves a lot of steps and procedures, he said.

First, we isolate the virus then you develop an antidote to that, followed by animal testing and then on human volunteers. Secondly, you see the efficacy, toxicity and then its longevity as to how long it sustains, Monga said.

He said since, the viral infections have shorter immunity; a vaccine with a longer effect is to be seen, secondly, we have to see that it has no side effect and thirdly, viruses mutate faster and hence, it has to be seen that the vaccine is effective on most of the mutants as we dont know which mutated virus is present in which part of the country.

Speaking about the rise in the recovery rate, Dr Monga said that in this particular disease, approximately 80 per cent of the people are recovering on their own.

These patients will automatically recover. Home isolation is a good thing, he said.

Monga said people using masks and adhering to social distancing norms is also increasing recovery.

However, he clarified that plasma therapy, which is being seen as the only solution to COVID-19 in place of the absence of the vaccine, cant minimise the need of a vaccine.

Here is the original post:
Covid-19 vaccine will reach usable stage after 2020: Expert - Northeast Now

Mysore/Mysuru: Nutrition is the cornerstone for a good physical and mental health and general well-being. In recent times, the subject of Nutrition and Dietetics seems to have caught the attention of students and public alike.

Sports Nutrition is yet another transdisciplinary subject which is focused on increasing awareness among health conscious and sports persons. In India, there is a huge gap between the need for sports Dietitian / Nutritionist and availability of one. This opens a great opportunity for students who are passionate in making their career in the field of Sports Nutrition.

Keeping in mind the ever- growing need of Sports Nutritionist in India and abroad, JSS Academy of Higher Education and Research, Mysuru, is starting a two-year Masters Degree programme in Sports Nutrition and Management from this academic year (September 2020-2021). The course will cover subjects like Sports Physiology, Sports Specific Diets, Nutritional Biochemistry, Human Nutrition, Basic Management subjects, among others.

With the knowledge that physical activity promotes good health and disease-free longevity and sports becoming a lucrative career choice, this course will benefit students who want to make a career as Sports Dietitian/ Nutritionist.

For information on the course, contact Dr. Vanitha Reddy on Mob: 95904-81932 or Dr. Shwetha on Mob: 78290-39578 or JSS AHER on Ph: 0821-2548400, according to a press release.

See original here:
Masters Degree in Sports Nutrition and Management at JSS - Star of Mysore

Rising star Jxdn (Jaden Hossler) and Travis Barker, who signed Jxdn to his DTA Records label.

Talk about a whirlwind year. Rising star Jxdn (whose real name is Jaden Hossler) is well on his way to biopic status at only 19. Don't believe me? Then how is this for the opening of a movie?

A kid living in Texas until the age of 14, moves to Tennessee, battles depression and overcomes two suicide attempts, moves to L.A., falls in love with music at a Juice WRLD concert and less than a year after that show is the first singing to Travis Barker's DTA label. and is personally taken under the rock icon's wing.

That is a hell of a start to a movie. For act two, Jxdn has released now three successful singles "Comatose," "Angels & Demons" and the latest, "So What," which features Barker and Machine Gun Kelly in the just released video.

But every great biopic needs a story of redemption of some kind. And Jaden Hossler is living that right now every day as I found when I spoke to him. I have known Barker for many years and have had numerous conversations about appreciating life after the plane crash that nearly killed him. So talking to the wise beyond his years Hossler about his gratitude and humility about his rapid rise to upcoming stardom it is no surprise that he and Barker have become kindred spirits.

I spoke with Hossler about his depression, his Juice WRLD fandom and how signing with Barker's DTA Records was the best decision he ever made in his life.

Steve Baltin: How is it going your first year in L.A.?When you have Travis Barker showing you around L.A. that is a good way to get introduced to the city.

Jaden Hossler: Yeah, it's been amazing. The whole thing with Travis happened probably last February. And since then it's been a lot easier for sure cause I got a big bro showing me around. It's been awesome.

Baltin: I heard from him how you came together. I'd like to hear it from your perspective as well.

Hossler: Basically I came out with my first single, "Comatose," February 26. The day after that I get a call from Travis, who was the first person to call us. It was a Wednesday morning. And he tells us, "My son just showed us this song," along with my producer, who produced it, who was an old friend of his. So it was two parts of his life coming together at once is how he describes it. And so he checked it out. He was the first catalyst of the movement. People heard about that, so all the record labels started hitting us up. So we flew to New York, did that whole process, came back out to L.A., met with everyone here, Interscope, Capitol, a bunch of different people. I thought we kind of had our mind made up, then I met with Travis in person. It was like, "Oh man, this is the guy I need to be with." We went to his vegan restaurant at Crossroads and that's when it settled for me this is the dude. He's so real, so humble and the fact he can be that way after doing everything he's done and working with all the people he's worked with, the fact he chose me to be his first signee, it's still a blessing to this day. But at the moment it was the biggest blessing I've ever had in my life. So we went with Travis and thank god I did because it was the best decision I think I've ever made. It's been awesome.

Baltin: Do you feel like you are learning more because he has been through so much in his own career he can share with you?

Hossler: He's more than just an artist at this point for me. He's like one of my best friends at this point. He's an engineer, a producer, a band member, a dad, a son, he's everything combined into one person. And like you mentioned the humility of everything, that is one thing I really try to harp on at this point because growing up as kids we're all entitled to our own pride at a certain point in our lives. And I definitely was living in that for a good portion of my life. Then I hit the lowest point when I hit a really deep depression. And I had near-death experiences myself, so the fact I get to connect with him with that on a real level speaks a lot more than numbers. I don't know everything at all and I will never say I do. Maybe before when I was in high school I might say I did. That's just me in my ignorance. Now that I've come out and live on my own in the real world, actually left the south for the first time, I realize that I do not know everything. And to have someone that basically kind of does is really nice because he lets me live my own life, give my own opinions and tells me whether they're gonna work or not. Even in the studio I'm like, "I really want to change this melody like this." And he goes, "No, dude, I'm telling you, you need to keep it like this, it goes better with everything." And then we end up going with what he says because I trust him beyond anything and he's right. So I love having that so much.

Baltin: Do you feel like having gone through depression and near-death experiences you have a different appreciation for where you are today?

Hossler: Absolutely, this is one thing I try to preach to other people because I've learned it myself. pain is a very important thing for people. A lot of people try to run from it. I did for most of my life, but you can't escape pain. What you can do is choose how you let it affect you. You can either let it destroy you or you can let it change you and help you become a better person. To my experience there was a lot of hate in my heart growing up. I went through a lot of things that drove me to hate myself and everyone around me. I didn't have appreciation for human life or anything like that. And then my senior year a situation happened with a very close person in my life that drove me to the darkest depression I've ever had in my life. I was really involved in school and in sports and my senior year I just dropped it all. I didn't go to school for like four months. I didn't even really leave my room. I lost like 20, 25 pounds, tried to commit suicide like twice. I really just didn't have any grasp at life. But after that last attempt and it just didn't work it really brought me out of this selfishness that I really just kind of surrounded myself with. Everything I was doing at that point was for myself and after that, one, I vowed to myself I would never lie. Before I lived off of lies and manipulation. I stopped lying, which people are scared about not lying because it could hurt you in the moment. But I promise it's so much better in the end if you'll just be honest to yourself and other people. Then two, I just started loving people.

Baltin: When did it change for you?

Hossler: It all came to fruition when I was at a Juice WRLD last July and in the middle of moshing to the song "Empty," which is tattooed on my arm, he is like my idol, the line, "I'm empty, I feel so goddamn empty," it opened my eyes in the middle of a mosh pit, just thousands of people were screaming this line. These kids, Juice WRLD and myself were all feeling this. They genuinely feel it. I realized I have to do something with music because I know how powerful it is. That moment is when I decided I want to start making music. I went in the studio, started making music and a couple of months later I released my first single, "Comatose." That's really how everything started snowballing. I chose rock music because it's authentic.

Baltin: Take me through some of the upcoming music.

Hossler: There is hope and that's what I want to give in my music. After "So What," I have a song called "Pray," which I'm really excited about because when you hear it you'll understand what I mean about how real it is. It just talks about the point in my life where I really just wanted to die. I wrote the first half of it a while back and then I just finished it like a week or so ago. And there's a complete shift. One I go up a couple of octaves and, two, I use the same word pattern and cadence, but I switch the words. So for instance I'll even give you an insider [preview]. One of the lines is, "I pray to god, let me die in my sleep." That's the first half of it. Then the second half is, "I pray to god I don't die in my sleep." And it's because I had that realization in my life there is so much more to live for. Drugs aren't the answer, alcohol is the answer, whatever you try to fill that void with is not the answer. The answer is genuinely finding a joy that it longevity and sustaining for yourself. For me that's loving other people, caring for other people, seeing the good in people when there is so much bad for everyone. And that's what I'm trying to implement in my music. That's what I'm doing.

Read more from the original source:
Q&A: Rising Star Jxdn On His Friendship With Travis Barker And Overcoming Depression - Forbes

Screenshot, Madeline Miller and David Mitchell in conversation.

It was just serendipity that the Chicago Humanities Festival scheduled two screenwriters with hot new novels two weeks in a row for their livestream show. Well, serendipity and the fact that the release dates were a week apart (July 7 and 14).

Last week, it was Charlie Kaufman (Anomalisa; Synecdoche, New York; andBeing JohnMalkovich) with his first novel,Antkind. This week, it was David Mitchell (Cloud Atlas,The Bone Clocksand eight novels) with his latest novel,Utopia Avenue.

This article is not a book review, but a report on the hosts conversations with two talented and idiosyncratic authors.

David Mitchells conversation with author Madeline Miller (her novels areSong of AchillesandCirce) turned out to be a mutual admiration fest.Miller did succeed in turning the conversation to Utopia Avenue and Mitchells other writings, but he came armed with a long list of questions, he said, about Millers two novels drawn from classic mythology; he flourished copies of both books to the video camera as he talked. Mitchell said hes a big admirer of Millers novels and so there was a lot of conversation about how Miller got interested in the classics (her mother read her The Iliad when she was 5 or 6), the longevity of myth, and the power of poetry in Homers writing.

Utopia Avenue is about a fictional British band in the 1960s (named Utopia Avenue after they decide against naming themselves The Way Out), and the four musicians who come together to make music and money. The band is formed under the guidance of a manager, Levon Frankland, who is a decent guy, not the stereotype evil dealer. Theres Elf (Elizabeth Frances), the keys player, vocalist and songwriter, who comes from the folk scene. Griff, the drummer, is a jazzer. Jasper is a virtuoso guitarist and songwriter and Dean is a talented, self-taught bassist and songwriter and former member of a band named Battleship Potemkin. (Jasper and Griff were with a sub-subpar band named Archie Kinnocks Blues Cadillac and Elf just broke up with her duo partner/boyfriend.)

The 60s were the early days of rock and roll and there were plenty of eclectic influences as bands began. The Stones were already well-established and enviably rich.

Mitchell, Lancashire-born and now living in County Cork, Ireland, has written a book larded with musical references, musical jargon, famous bands and track titles. Jasper meets a still-unknown David Bowie while leaving the bands management office. There are cameo appearances by famous musicians like Syd Barrett, Jimi Hendrix and Leonard Cohen.

When Miller asks Mitchell about works that influenced this book, he names the Canadian band Rush because of their high register vocabulary, Dr. Who and Isaac Asimovs Foundationseries .And one more thing: the childrens book series, Flat Stanley. As Flat Stanley found, upon becoming flat, a curse is a blessing and a blessing is a curse.

Mitchell isnt a musician but he admires the instant feedback loop that musicians have in live performance. Im jealous of that, he said, and commented that music is important to us from the womb on (when we are conscious of the bass track of our mothers heartbeat) and then in adolescence, when music is a tribal identifier. We have a primal relationship with music throughout our lives.

The musicians intention is changed by the listener, who adds personal meaning to the musicians work. And a novel cant make the reader hear the music, Mitchell acknowledged, but it can show its effect on human beings.

His descriptions of the bands early gigs are realistic, with the musicians terrified and their audiences in turn bored or insultingand later their audiences become adoring fans. The band members play off each other; they are strangers at first and become a unit. They start by playing in grungy, mostly empty college halls and rural bars. They travel in a decrepit van they call the Beast. It barely runs but it carries all their gear, amps and Griffs drum kit.

Miller commented on the interconnectedness of Mitchells novels: characters or incidents in one novel appear in others. He does that, he says, because it pleases me to do it. My characters get away and may have a future in another book. Im sometimes thinking three books ahead, he said.

Screenshot. Greta Johnsen and Charlie Kaufman discuss his book.

Antkind, the quirky, circuitous story of a film critic, and Kaufmans other writing was the subject of his conversation with Greta Johnsen (WBEZ and the Nerdette podcast) last week.

In Antkind, B. Rosenberger Rosenberg, the not-Jewish film critic, drives through Florida, trying to keep his windshield bugfree and stopping at a Slammys for a biggy cola and paper towels. He has an African American girlfriend (you would know her name), a relationship of which hes inordinately proud. Hes headed for the St. Augustine Film History building, the architecture of which recreates the head of The Creature from the Black Lagoon,filmed nearby.. (The vault is in the chin; the screening room is in the left gill.) B. is there to do research for a monograph on a Black filmmaker.

The film critic serves partly as Kaufmans opportunity to lampoon film critics (they can write about you but you cant write about them). B. is a jerk, Kaufman says, has a deep need for approval, and hates the work of Charlie Kaufman. The book is often self-referential and in current argot, meta.

Mitchell explains the musicians intention being completed by the listeners experience and emotional state. Kaufman says a piece of work is completed by the readerit goes into your brain.

The main plot line of Antkind concerns the ancient outsider filmmaker that B. meets who has been working for 90 years on a stop-motion animation film with an army of puppets. Watching the film takes three months. B. decides this masterpiece could be the greatest discovery in the history of cinema plus it could save his foundering career. His attempt to bring the film to cinema royalty is the main story thread among many.

Kaufman is being interviewed from his temporary New York apartment. Johnsen asks him if he knew where he was going when he started writing the book, which, by the way, runs 720 pages. Not at the beginning, he says. I like to explore, sort of free form.I didnt know if it would be funny or something else. I tried writing in third person, then first person. (Its written from B.s perspective, in B.s voice.)

Johnsen asks him when he knew he was done. He worked on the book for five-and-a-half years, Kaufman said, and after about five years, he knew where he was goingbut thats by design. Everything is anxiety-inducing for me, he says, so I just add that to it (the anxiety).

Are there books that Antkind is in conversation with? Johnsen asks. Like Kafka, David Foster Wallace, Pynchon. He acknowledges that Kafka has been a big influence on his life and on his thinking. And I used to read a lot of Philip K. Dick, but not recently. Everything feels very of the moment.

Do you ever have writers block? Johnsen asks the standard issue question to a writer. Well, if I do, therere always things percolating even when you dont know they are. (So we might think of writers block as a different form of creativity.)

Charlie Kaufman has a thing for hirsuteness. He begins Antkind with a first-person homage by B. to his beard.

My beard is a wonder. It is the beard of Whitman, of Rasputin, of Darwin, yet it is uniquely mine. Its a salt-and-pepper, steel-wool, cotton-candy confection, much too long, wispy, and unruly to be fashionable. And it is this, its very unfashionability, that makes the strongeststatement. It says, I dont care a whit (a Whitman) about fashion. I dont care about attractiveness. This beard is too big for my narrow face. This beard is too wide. This beard is too bottom-heavy for my bald head. And on and on. Its what he calls his beard monologue.

In a 2015 photo of Kaufman from some film festival, his beard is thick, longish (not a goatee) and dark although not unruly. Hes also definitely not bald. Thick dark curly hair. So Im a little surprised when he Zooms onscreen to converse with Greta Johnsen. His hair is moderately cropped and ruly and hes beardless, but has a big old porn-star mustache.

As to the books themselves, Ive read the first 100 pages of Utopia Avenue and a little less of Antkind (in e-galley versions from the publisher). Utopia Avenue is immediately engrossing, as Mitchell introduces the band members and the London music setting of the late 1960s. I can tell by the smart and funny dialogue among the musicians, as well as hints of whats to come, that Im going to love Utopia Avenue. I know that its at least partly because Im smitten with the pop/rock music scene that UA immediately appeals to me.

Antkind feels as if it will be a novelized version of some of Kaufmans quirky films like Eternal Sunshine of the Spotless Mind and Being John Malkovich. I didnt find the first section that I read as appealing as the other book, but Ive always felt you should read 100 pages of a book before deciding if you want to finish it or not.

Finally, I just want to say something about longggggg books. Mitchells is 574 pages and Kaufmans is 720 pages in print. Now Ive always been a devoted reader and Ive read my share of 700-page doorstops. Im looking at you Ron Chernow with your eye-opening Hamilton biography and David McCulloughs John Adamsor Simon Schamas glorious Citizens: A Chronicle of the French Revolution at 900 pages! But those are all nonfiction. Of course, theres Ulysses (no, Ive never finished it) and Tom Wolfes Bonfire of the Vanities, which I devoured every word of. But whats wrong with a nice 300-page novel? I like a book that fits in my bag when Im commuting or traveling and that doesnt turn my arm numb when Im reading in bed. (Yes, I do read on a Kindle, but I prefer a real book.)

Maybe the pandemic is the time to finally read Ulysses from cover to cover.

Related

Categories: Events, Lit, Live Lit, Stages

Tagged as: Antkind, Charlie Kaufman, CHF, Chicago Humanities Festival, David Mitchell, Greta Johnsen, Madeline Miller, PenguinRandomHouse, Utopia Avenue

More:
Conversations: Two Screenwriters Talk About Their New NovelsUtopia Avenue and Antkind - thirdcoastreview.com

THURSDAY, July 16, 2020 (HealthDay News) -- Bats have been blamed as a possible source of the new coronavirus pandemic ravaging the globe. But they might also point to possible ways out of it.

Scientists say the winged mammals' immune systems may offer clues on how to fight the new coronavirus and other dangerous viruses in humans.

"Humans have two possible strategies if we want to prevent inflammation, live longer and avoid the deadly effects of diseases like COVID-19," explained study lead author Vera Gorbunova, a professor of biology at the University of Rochester in New York. "One would be to not be exposed to any viruses, but that's not practical. The second would be to regulate our immune system more like a bat."

Many deadly viruses that affect people are believed to have originated in bats, including rabies, Ebola and SARS-CoV-2, the strain that causes COVID-19. But bats have evolved a secret weapon: They're better able to tolerate viruses than humans and other mammals.

"We've been interested in longevity and disease resistance in bats for a while, but we didn't have the time to sit and think about it," Gorbunova said in a university news release.

"Being in quarantine gave us time to discuss this, and we realized there may be a very strong connection between bats' resistance to infectious diseases and their longevity. We also realized that bats can provide clues to human therapies used to fight diseases," she explained.

Typically, a species' lifespan is associated with its body size. The smaller a species, the shorter its lifespan. But many bat species have lifespans of 30 to 40 years, which is impressive for their size, the authors noted in a review article published recently in Cell Metabolism.

Bats' longevity and tolerance to viruses may be due to their ability to control inflammation, which is involved in both aging and disease. Viruses, including COVID-19, can trigger inflammation.

With COVID-19, this inflammatory response goes "haywire," Gorbunova said. In fact, in many cases it is the inflammatory response that kills the patient, more so than the virus itself.

"The human immune system works like that: Once we get infected, our body sounds an alarm and we develop a fever and inflammation. The goal is to kill the virus and fight infection, but it can also be a detrimental response as our bodies overreact to the threat," Gorbunova said.

In contrast, bats' immune systems control viruses without mounting a strong inflammatory response.

There are several possible reasons why bats evolved to fight viruses and live long lives. Flight may be one of them, the researchers noted.

Bats are the only mammals that can fly, which required them to adapt to rapid increases in body temperature, sudden surges in metabolism and molecular damage. These adaptations may also assist in disease resistance, the study authors suggested.

Another factor is that many species of bats live in large, dense colonies, and hang close together on cave ceilings or in trees. Those conditions are ideal for transmitting viruses and other pathogens.

According to Andrei Seluanov, a biology professor at the University of Rochester, "Bats are constantly exposed to viruses. They are always flying out and bringing back something new to the cave or nest, and they transfer the virus because they live in such close proximity to each other."

This means that bats' immune systems are continuously adapting to deal with new viruses. Studying bats' immune systems could lead to new ways to fight aging and diseases in humans, the researchers said.

More information

The U.S. Centers for Disease Control and Prevention has more on COVID-19.

Read the original here:
Coronavirus May Have Come From Bats; Could They Also Hold Clues to Treatments? - HealthDay News